Moody Aldrich Partners LLC Zymeworks Inc. Transaction History

Moody Aldrich Partners LLC

  • $475 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
$26.5 - $38.23 $880,542 - $1.27 Million
-33,228 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$29.83 - $56.81 $12,051 - $22,951
404 Added 1.23%
33,228 $1.05 Million
Q3 2020

Nov 12, 2020
BUY
$29.21 - $46.58 $22,988 - $36,658
787 Added 2.46%
32,824 $1.53 Million
Q2 2020

Jul 30, 2020
BUY
$33.67 - $40.0 $1.08 Million - $1.28 Million
32,037 New
32,037 $1.16 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $903M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email